Taiwan FDA registration ce5ba894c05256126891c9f7016780df
Omron blood glucose test tablets second generation
TW: 歐姆龍血糖試片二代
Taiwan·Risk Class 2·DELBIO INC.·Registered May 23, 2013 – May 23, 2018CancelledRegistration details
- Analysis ID
- ce5ba894c05256126891c9f7016780df
Company information
- Manufacturer
- DELBIO INC.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- DELBIO INC.
Product details
- Intended Use
- This product is used with Omron blood glucose meter - safe and safe, and can quantitatively detect the blood glucose value of fingertip and palm microvascular whole blood, and is not suitable for neonatal testing.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- Domestic
Dates and status
- Registration Date
- May 23, 2013
- Expiry Date
- May 23, 2018
- Cancellation Date
- Dec 13, 2019
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Omron blood glucose test tablets second generation in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ce5ba894c05256126891c9f7016780df and manufactured by DELBIO INC.. The authorized representative in Taiwan is DELBIO INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices